Muensterman E, Torres JA and Weimbs T. (2026) Real-world outcomes of managing autosomal-dominant polycystic kidney disease using a medical food as part of a nutrition and lifestyle program to improve renal and metabolic health. Frontiers in Nutrition 12:1624639.
https://doi.org/10.3389/fnut.2025.1624639
Johnson RJ, Bjornstad P, Weimbs T. Citrate in the Management of Gout, Urate Nephrolithiasis and Kidney Disease: An Old Therapy Rediscovered? Rheumatology (Oxford). 2025 ;64:5206–5207.
https://doi.org/10.1093/rheumatology/keaf352
Athinarayanan SJ, Roberts CGP, Phinney SD, Weimbs T, Friedman AN, Volek JS. Effects of a continuous remote care intervention including nutritional ketosis on kidney function and inflammation in adults with type 2 diabetes: a post-hoc latent class trajectory analysis. Frontiers in Nutrition. 2025; 12:1609737.
Messing, Melina, Jacob A. Torres, Nickolas Holznecht, and Thomas Weimbs.
Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.
Nutrients 16, no. 19 (January 2024): 3281.
https://doi.org/10.3390/nu16193281.
Torres, J. A.; Holznecht, N.; Asplund, D. A.; Kroes, B. C.; Amarlkhagva, T.; Haeffner, M. M.; Sharpe, E. H.; Koestner, S.; Strubl, S.; Schimmel, M. F.; Kruger, S.; Agrawal, S.; Aceves, B. A.; Thangaraju, M.; Weimbs, T.
β-Hydroxybutyrate Recapitulates the Beneficial Effects of Ketogenic Metabolic Therapy in Polycystic Kidney Disease.
iScience 27, no. 9 (September 20, 2024).
https://doi.org/10.1016/j.isci.2024.110773.
Athinarayanan, Shaminie J., Caroline G. P. Roberts, Chandan Vangala, Greeshma K. Shetty, Amy L. McKenzie, Thomas Weimbs, and Jeff S. Volek.
The Case for a Ketogenic Diet in the Management of Kidney Disease.
BMJ Open Diabetes Research & Care 12, no. 2 (April 27, 2024): e004101
https://doi.org/10.1136/bmjdrc-2024-004101
Torres, Jacob A., Nickolas Holznecht, David A. Asplund, Tselmeg Amarlkhagva, Bradley Kroes, Juliette Rebello, Shagun Agrawal, and Thomas Weimbs.
A Combination of SS-Hydroxybutyrate and Citrate Ameliorates Disease Progression in a Rat Model of Polycystic Kidney Disease.
American Journal of Physiology. Renal Physiology 326 (December 14, 2023): F352–68
https://doi.org/10.1152/ajprenal.00205.2023
Weimbs, Thomas, Jessianna Saville, and Kamyar Kalantar-Zadeh.
Ketogenic Metabolic Therapy for Chronic Kidney Disease - The Pro Part.
Clinical Kidney Journal 17(1), no. sfad273 (2023): sfad273.
https:/doi.org/10.1093/ckj/sfad273
Cukoski, S.; Lindemann, C. H.; Arjune, S.; Todorova, P.; Brecht, T.; Kühn, A.; Oehm, S.; Strubl, S.; Becker, I.; Kämmerer, U.; Torres, J. A.; Meyer, F.; Schömig, T.; Hokamp, N. G.; Siedek, F.; Gottschalk, I.;
Benzing, T.; Schmidt, J.; Antczak, P.; Weimbs, T.; Grundmann, F.; Müller, R.-U.
Feasibility and Impact of Ketogenic Dietary Interventions in Polycystic Kidney Disease: KETO-ADPKD—a Randomized Controlled Trial.
Cell Reports Medicine (2023), 4 (11), 101283.
https://doi.org/10.1016/j.xcrm.2023.101283
Cukoski, S.; Kühn, A.; Lindemann, C. H.; Arjune, S.; Meyer, F.; Schömig, T.; Große-Hokamp, N.; Schmidt, J.; Antczak, P.; Weimbs, T.; Grundmann, F.; Mueller, R.-U.
Ketosis Moderates the Effect on Kidney Volume in Dietary Interventions for ADPKD—More Insights on the KETO ADPKD Trial.
Nephrology Dialysis Transplantation (2024), 39 (Supplement_1), gfae069-0738–2160.
https://doi.org/10.1093/ndt/gfae069.738
Oehm, S.; Steinke, K.; Schmidt, J.; Arjune, S.; Todorova, P.; Heinrich Lindemann, C.; Wöstmann, F.; Meyer, F.; Siedek, F.; Weimbs, T.; Müller, R.-U.; Grundmann, F.
RESET-PKD: A Pilot Trial on Short-Term Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease.
Nephrology Dialysis Transplantation (2023), 38 (7), 1623–1635.
https://doi.org/10.1093/ndt/gfac311
Bruen DM, Kingaard JJ, Munits M, Paimanta CS, Torres JA, Saville J, Weimbs T.
Ren.Nu, a Dietary Program for Individuals with Autosomal-Dominant Polycystic Kidney Disease Implementing a Sustainable, Plant-Focused, Kidney-Safe, Ketogenic Approach with Avoidance of Renal Stressors.
Kidney and Dialysis (2022) 2:183-203
Strubl S, Oehm S, Torres JA, Grundmann F, Haratani J, Decker M, Vuong S, Bhandal AK, Methot N, Haynie-Cion R, Meyer F, Siedek F, Korst U, Müller RU, Weimbs T. Ketogenic Dietary Interventions in Autosomal-Dominant Polycystic Kidney Disease (ADPKD)– A Retrospective Case Series Study: First insights into Feasibility, Safety and Effects.
Clinical Kidney Journal (2021) 15:1079-1092
Torres, J. A.; Rezaei, M.; Broderick, C.; Lin, L.; Wang, X.; Hoppe, B.; Cowley, B. D.; Savica, V.; Torres, V. E.; Khan, S.; Holmes, R. P.; Mrug, M.; Weimbs, T.
Crystal Deposition Triggers Tubule Dilation That Accelerates Cystogenesis in Polycystic Kidney Disease.
J Clin Invest (2019), 129 (10), 4506–4522.
https://doi.org/10.1172/JCI128503
Allison, Susan J.
Crystal Deposition Aids Cystogenesis.
Nature Reviews Nephrology 15, no. 12 (December 2019): 730–730.
https://doi.org/10.1038/s41581-019-0215-7
Torres, J. A.; Kruger, S. L.; Broderick, C.; Amarlkhagva, T.; Agrawal, S.; Dodam, J. R.; Mrug, M.; Lyons, L. A.; Weimbs, T.
Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.
Cell Metab (2019), 30 (6), 1007-1023.e5.
https://doi.org/10.1016/j.cmet.2019.09.012
Carney, Ellen F.
Ketosis Slows the Progression of PKD.
Nature Reviews Nephrology 16, no. 1 (January 2020): 1–1.
https://doi.org/10.1038/s41581-019-0226-4
